Monashee Investment Management LLC - SATSUMA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Monashee Investment Management LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$832,000
-20.0%
118,027
-33.0%
0.10%
-37.5%
Q1 2021$1,040,000
+10.9%
176,057
+181.7%
0.16%
-62.6%
Q3 2019$938,00062,5000.43%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,711,286$22,268,0003.58%
NEA Management Company, LLC 3,142,958$18,858,0000.94%
Vivo Capital, LLC 1,232,394$7,394,0000.82%
RA Capital Management 5,914,252$35,486,0000.76%
Nan Fung Group Holdings Ltd 177,900$1,067,0000.68%
Ikarian Capital, LLC 400,000$2,400,0000.48%
SAMLYN CAPITAL, LLC 2,929,195$17,575,0000.33%
EAM Investors, LLC 149,029$894,0000.19%
TPG GP A, LLC 1,885,939$11,316,0000.18%
Ikarian Capital, LLC 136,059$815,0000.16%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders